recent articles

CND Biomarker Testing Services Utilizing Groundbreaking NerValence™ System Unveiled at the AD/PD™ 2024 Parkinson's and Alzheimer's Disease Conference SCOTTSDALE, Ariz.., March 5, 2024 /PRNewswire/ -- CND Life Sciences (CND), a...

Evident, Corista, Sakura Finetek USA and Visiopharm team up to drive quality and efficiency in pathology WALTHAM, Mass., Sept. 6, 2023—Evident announced an alliance with Corista, Sakura Finetek USA and Visiopharm to deliver an automated,...

Visiopharm and Boston Cell Standards Partnership: Solution combining first AI-Driven IHC Levey-Jennings software with first quantitative IHC reference materials will enable labs to meet proposed regulatory changes COPENHAGEN, Denmark &...

NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications to assist in diagnosing cancer, today announced it is working with Visiopharm, an artificial intelligence (AI)-driven...

March 2, 2023 - Visiopharm, a leading provider of AI-driven precision pathology software, has announced the launch of a next-generation Ki67 algorithm providing diagnostic decision support for pathologists. The algorithm, which has been cleared...

Visiopharm today announces that it will be entering into a research pilot with Massachusetts General Hospital (MGH) to investigate the use of AI-powered precision pathology solutions for quality assurance of immunohistochemistry (IHC)...

OR

platinum partners

gold partners

Silver Partners

Media Partners